a public good project by the
Synthesis
Company
of California

© 2026

Carole A. Long | doi.page

0 works0 citations0 h-index

Carole A. Long

National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)

Publications by Year

Research Areas

Malaria Research and Control, Mosquito-borne diseases and control, Complement system in diseases, HIV Research and Treatment, Invertebrate Immune Response Mechanisms

Most-Cited Works

→ Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody(2013)924 cited
→ Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51(2008)453 cited
→ Malaria Vaccines: Recent Advances and New Horizons(2018)343 cited
→ The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody(2011)284 cited
→ Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria(2005)251 cited
→ Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines(2007)246 cited

→ In Vitro Studies with RecombinantPlasmodium falciparumApical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response(2002)243 cited

→ Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria(2005)236 cited

→ A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys(2015)233 cited

→ ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans(2012)224 cited